Sandra Anne Banack Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

11/2023	A Direct Analysis of β-N-methylamino-l-alanine Enantiomers and Isomers and Its Application to Cyanobacteria and Marine Mollusks.
1/2023	Detection of β-N-methylamino-l-alanine in postmortem olfactory bulbs of Alzheimer's disease patients using UHPLC-MS/MS: An autopsy case-series study.
10/2021	BMAA, Methylmercury, and Mechanisms of Neurodegeneration in Dolphins: A Natural Model of Toxin Exposure.
1/2018	Methods for the Chemical Analysis of β-N-Methylamino-L-A lanine: What Is Known and What Remains to Be Determined.
1/2013	The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregation.
12/2010	The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
5/2010	Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
1/2009	Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.
8/2004	A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
11/2003	Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Anne Banack Research Topics

Disease

11	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 08/2004
10	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 11/2003
6	Dementia (Dementias) 01/2020 - 08/2004
6	Parkinsonian Disorders (Parkinsonism) 01/2020 - 08/2004
5	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 08/2004
2	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2020 - 01/2020
2	Amyloid Plaque 01/2018 - 01/2016
1	Insulin Resistance 12/2022
1	Autistic Disorder (Autism) 12/2022
1	Disease Progression 01/2020
1	Gliosis 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2013
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2013
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Ataxia (Dyssynergia) 01/2013
1	Lewy Body Disease (Lewy Body Dementia) 01/2013

Drug/Important Bio-Agent (IBA)

10	Alanine (L-Alanine)FDA Link 11/2023 - 01/2013
6	Amino Acids FDA Link 11/2023 - 08/2004
5	Cyanobacteria ToxinsIBA 01/2015 - 11/2003
4	beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)IBA 01/2018 - 09/2006
3	Serine (L-Serine)FDA Link 12/2022 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2010
2	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2020
1	Messenger RNA (mRNA)IBA 12/2022
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 12/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2022
1	Protein AggregatesIBA 01/2020
1	MicrocystinsIBA 01/2015
1	Ala Transfer RNAIBA 01/2013